| NCT03317015 |
A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT03317015 |
Completed |
Sanofi |
2017-07-10 |
| NCT02709538 |
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT02709538 |
Completed |
Glenmark Specialty S.A. |
2017-07-31 |
| NCT02686294 |
Repeated Dosing Clinical Trial of HL151 |
https://ClinicalTrials.gov/show/NCT02686294 |
Completed |
Hanlim Pharm. Co., Ltd. |
2016-03-15 |
| NCT02682745 |
Single Dosing Clinical Trial of HL151 |
https://ClinicalTrials.gov/show/NCT02682745 |
Completed |
Hanlim Pharm. Co., Ltd. |
2016-02-12 |
| NCT02532179 |
Subcutaneous Immunotherapy for Mouse in Adults |
https://ClinicalTrials.gov/show/NCT02532179 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-10-31 |
| NCT02498509 |
Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 |
https://ClinicalTrials.gov/show/NCT02498509 |
Completed |
Chong Kun Dang Pharmaceutical |
2016-03-31 |
| NCT02443805 |
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR |
https://ClinicalTrials.gov/show/NCT02443805 |
Completed |
Stallergenes Greer |
2018-06-25 |
| NCT02424539 |
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR) |
https://ClinicalTrials.gov/show/NCT02424539 |
Completed |
GlaxoSmithKline |
2017-10-25 |
| NCT02397915 |
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays |
https://ClinicalTrials.gov/show/NCT02397915 |
Completed |
GlaxoSmithKline |
2015-06-08 |
| NCT02339714 |
Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT02339714 |
Completed |
China Academy of Chinese Medical Sciences |
2016-05-31 |
| NCT02182544 |
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT02182544 |
Completed |
Boehringer Ingelheim |
2001-12-31 |
| NCT02182518 |
Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT02182518 |
Completed |
Boehringer Ingelheim |
2001-07-31 |
| NCT01287364 |
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01287364 |
Completed |
Sunovion |
2011-04-30 |
| NCT01270958 |
A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01270958 |
Completed |
GlaxoSmithKline |
2010-02-28 |
| NCT01270256 |
NasoNeb Delivery of an Intranasal Steroid |
https://ClinicalTrials.gov/show/NCT01270256 |
Completed |
University of Chicago |
2012-07-31 |
| NCT03360071 |
A Novel Biologic Therapy for Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT03360071 |
Completed |
Johns Hopkins University |
2018-06-30 |
| NCT01982916 |
Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean |
https://ClinicalTrials.gov/show/NCT01982916 |
Completed |
Ahn-Gook Pharmaceuticals Co.,Ltd |
2015-01-31 |
| NCT01962467 |
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine |
https://ClinicalTrials.gov/show/NCT01962467 |
Completed |
GlaxoSmithKline |
2014-02-27 |
| NCT01957202 |
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) |
https://ClinicalTrials.gov/show/NCT01957202 |
Completed |
GlaxoSmithKline |
2014-02-28 |
| NCT01949051 |
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01949051 |
Completed |
GlaxoSmithKline |
2014-02-04 |
| NCT01918033 |
A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) |
https://ClinicalTrials.gov/show/NCT01918033 |
Completed |
Merck Sharp & Dohme Corp. |
2014-01-26 |
| NCT01900054 |
A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01900054 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2013-11-30 |
| NCT01861522 |
The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01861522 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2013-12-31 |
| NCT01852812 |
Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) |
https://ClinicalTrials.gov/show/NCT01852812 |
Completed |
Merck Sharp & Dohme Corp. |
2013-12-24 |
| NCT01779895 |
Probiotic Administration and Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01779895 |
Completed |
Nestlé |
2013-01-31 |
| NCT01700192 |
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) |
https://ClinicalTrials.gov/show/NCT01700192 |
Completed |
ALK-Abelló A/S |
2015-04-30 |
| NCT01697956 |
Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT01697956 |
Completed |
Teva Pharmaceutical Industries |
2013-02-28 |
| NCT01678807 |
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) |
https://ClinicalTrials.gov/show/NCT01678807 |
Completed |
ALK-Abelló A/S |
2013-05-31 |
| NCT01654536 |
A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT01654536 |
Completed |
Sunovion |
2013-07-31 |
| NCT01644617 |
A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) |
https://ClinicalTrials.gov/show/NCT01644617 |
Completed |
ALK-Abelló A/S |
2013-08-31 |
| NCT01640535 |
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients |
https://ClinicalTrials.gov/show/NCT01640535 |
Completed |
Hanmi Pharmaceutical Company Limited |
2013-02-28 |
| NCT01630135 |
Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01630135 |
Completed |
GlaxoSmithKline |
2012-08-31 |
| NCT01622283 |
Pharmacokinetic Study of Levocetirizine Oral Solution |
https://ClinicalTrials.gov/show/NCT01622283 |
Completed |
GlaxoSmithKline |
2012-06-10 |
| NCT01622231 |
Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01622231 |
Completed |
GlaxoSmithKline |
2012-11-30 |
| NCT01539304 |
Clinical Trial to Evaluate the Safety and Efficacy of “CITUS Dry Syrup” in Children With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01539304 |
Completed |
SamA Pharmaceutical Co., Ltd |
2011-08-31 |
| NCT01470053 |
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01470053 |
Completed |
Hanlim Pharm. Co., Ltd. |
2011-12-31 |
| NCT01451541 |
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). |
https://ClinicalTrials.gov/show/NCT01451541 |
Completed |
Sunovion |
2012-12-31 |
| NCT01425632 |
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01425632 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2011-12-31 |
| NCT01401465 |
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray |
https://ClinicalTrials.gov/show/NCT01401465 |
Completed |
Sunovion |
2011-11-30 |
| NCT01380327 |
Biomarkers of Cockroach Sublingual Immunotherapy 2 |
https://ClinicalTrials.gov/show/NCT01380327 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-06-30 |
| NCT01378429 |
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01378429 |
Completed |
Sunovion |
2011-11-30 |
| NCT04388358 |
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation |
https://ClinicalTrials.gov/show/NCT04388358 |
Recruiting |
Chang Gung Memorial Hospital |
2020-07-31 |
| NCT04332978 |
Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene |
https://ClinicalTrials.gov/show/NCT04332978 |
Completed |
Libbs Farmacêutica LTDA |
2020-04-01 |
| NCT04324918 |
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT04324918 |
Completed |
Hanmi Pharmaceutical Company Limited |
2019-06-24 |
| NCT04024033 |
Effects of Pine Cone Extract on Serum IgE Levels in Perennial Rhinitis |
https://ClinicalTrials.gov/show/NCT04024033 |
Active, not recruiting |
University of South Florida |
2020-01-31 |
| NCT03655210 |
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients |
https://ClinicalTrials.gov/show/NCT03655210 |
Completed |
Hanlim Pharm. Co., Ltd. |
2017-02-20 |
| NCT01244217 |
Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT01244217 |
Completed |
Sanofi |
2011-07-31 |
| NCT01231464 |
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01231464 |
Completed |
GlaxoSmithKline |
2010-05-31 |
| NCT01228630 |
Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis. |
https://ClinicalTrials.gov/show/NCT01228630 |
Completed |
Azidus Brasil |
2012-04-30 |
| NCT01221285 |
Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium |
https://ClinicalTrials.gov/show/NCT01221285 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-10-31 |
| NCT01216384 |
Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers |
https://ClinicalTrials.gov/show/NCT01216384 |
Completed |
Boehringer Ingelheim |
2010-12-31 |
| NCT01165424 |
A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) |
https://ClinicalTrials.gov/show/NCT01165424 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT01154153 |
Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01154153 |
Completed |
Sanofi |
2010-10-31 |
| NCT01135134 |
Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) |
https://ClinicalTrials.gov/show/NCT01135134 |
Completed |
Merck Sharp & Dohme Corp. |
2010-10-31 |
| NCT01134705 |
Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) |
https://ClinicalTrials.gov/show/NCT01134705 |
Completed |
Teva Pharmaceutical Industries |
2010-10-31 |
| NCT01133626 |
Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT01133626 |
Completed |
Teva Pharmaceutical Industries |
2010-09-30 |
| NCT01127620 |
Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension |
https://ClinicalTrials.gov/show/NCT01127620 |
Completed |
Faes Farma, S.A. |
2006-03-31 |
| NCT01116778 |
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01116778 |
Completed |
GenMont Biotech Incorporation |
2012-01-31 |
| NCT01115595 |
Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais |
https://ClinicalTrials.gov/show/NCT01115595 |
Completed |
Mahidol University |
2013-10-31 |
| NCT01067105 |
A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older |
https://ClinicalTrials.gov/show/NCT01067105 |
Completed |
Sunovion |
2010-11-30 |
| NCT01033825 |
Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis |
https://ClinicalTrials.gov/show/NCT01033825 |
Completed |
Sunovion |
2010-05-31 |
| NCT01018862 |
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01018862 |
Completed |
Meda Pharmaceuticals |
2011-04-30 |
| NCT00988247 |
Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00988247 |
Completed |
Teva Pharmaceutical Industries |
2011-02-28 |
| NCT00974571 |
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) |
https://ClinicalTrials.gov/show/NCT00974571 |
Completed |
Merck Sharp & Dohme Corp. |
2002-05-31 |
| NCT00963573 |
Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) |
https://ClinicalTrials.gov/show/NCT00963573 |
Completed |
Merck Sharp & Dohme Corp. |
2006-11-30 |
| NCT00953147 |
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older |
https://ClinicalTrials.gov/show/NCT00953147 |
Completed |
Sunovion |
2010-01-31 |
| NCT00894231 |
Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00894231 |
Completed |
AAADRS Clinical Research Center |
2009-08-31 |
| NCT00848965 |
A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber |
https://ClinicalTrials.gov/show/NCT00848965 |
Completed |
GlaxoSmithKline |
2008-01-31 |
| NCT00839189 |
Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults |
https://ClinicalTrials.gov/show/NCT00839189 |
Completed |
University of North Carolina, Chapel Hill |
2006-06-30 |
| NCT00829985 |
Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) |
https://ClinicalTrials.gov/show/NCT00829985 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-12-31 |
| NCT00822406 |
Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00822406 |
Completed |
University of Sao Paulo |
NA |
| NCT01916226 |
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT01916226 |
Completed |
GlaxoSmithKline |
2013-10-01 |
| NCT00806754 |
Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) |
https://ClinicalTrials.gov/show/NCT00806754 |
Completed |
AstraZeneca |
2007-05-31 |
| NCT00794846 |
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) |
https://ClinicalTrials.gov/show/NCT00794846 |
Completed |
Merck Sharp & Dohme Corp. |
2003-05-31 |
| NCT00794599 |
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) |
https://ClinicalTrials.gov/show/NCT00794599 |
Completed |
Merck Sharp & Dohme Corp. |
2003-08-31 |
| NCT00794495 |
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) |
https://ClinicalTrials.gov/show/NCT00794495 |
Completed |
Merck Sharp & Dohme Corp. |
2003-07-31 |
| NCT00789555 |
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00789555 |
Completed |
Alcon Research |
2011-01-31 |
| NCT00783224 |
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) |
https://ClinicalTrials.gov/show/NCT00783224 |
Completed |
Merck Sharp & Dohme Corp. |
2005-11-30 |
| NCT00779740 |
Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) |
https://ClinicalTrials.gov/show/NCT00779740 |
Completed |
Merck Sharp & Dohme Corp. |
2005-04-01 |
| NCT00779545 |
A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00779545 |
Completed |
Merck Sharp & Dohme Corp. |
2004-08-06 |
| NCT00771160 |
MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00771160 |
Completed |
Merck Sharp & Dohme Corp. |
2005-02-28 |
| NCT00741897 |
Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00741897 |
Completed |
Sanofi |
2003-12-31 |
| NCT00732368 |
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) |
https://ClinicalTrials.gov/show/NCT00732368 |
Completed |
Merck Sharp & Dohme Corp. |
2006-01-01 |
| NCT00730912 |
Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539) |
https://ClinicalTrials.gov/show/NCT00730912 |
Completed |
Merck Sharp & Dohme Corp. |
2008-12-31 |
| NCT00730756 |
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis |
https://ClinicalTrials.gov/show/NCT00730756 |
Completed |
GlaxoSmithKline |
2009-02-28 |
| NCT00720382 |
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00720382 |
Completed |
Meda Pharmaceuticals |
2008-06-30 |
| NCT00712920 |
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies |
https://ClinicalTrials.gov/show/NCT00712920 |
Completed |
Meda Pharmaceuticals |
2008-05-31 |
| NCT00682643 |
A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00682643 |
Completed |
GlaxoSmithKline |
2011-02-28 |
| NCT00659750 |
To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) |
https://ClinicalTrials.gov/show/NCT00659750 |
Completed |
AstraZeneca |
2004-05-31 |
| NCT00659048 |
Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) |
https://ClinicalTrials.gov/show/NCT00659048 |
Completed |
AstraZeneca |
2005-04-30 |
| NCT00658918 |
To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) |
https://ClinicalTrials.gov/show/NCT00658918 |
Completed |
AstraZeneca |
2005-04-30 |
| NCT00641212 |
Children, Perennial Allergic Rhinitis (PAR), l-t Growth |
https://ClinicalTrials.gov/show/NCT00641212 |
Completed |
AstraZeneca |
2003-04-30 |
| NCT00639587 |
Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00639587 |
Completed |
UCB Pharma |
2003-03-31 |
| NCT00638755 |
The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00638755 |
Completed |
Capnia, Inc. |
2008-05-31 |
| NCT00609674 |
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00609674 |
Completed |
GlaxoSmithKline |
2008-06-30 |
| NCT00590772 |
The Role of Montelukast in Rhinitis and Sleep |
https://ClinicalTrials.gov/show/NCT00590772 |
Completed |
Penn State University |
2009-01-31 |
| NCT00578331 |
Safety Study of Olopatadine Nasal Spray |
https://ClinicalTrials.gov/show/NCT00578331 |
Completed |
Alcon Research |
2008-01-31 |
| NCT00570492 |
Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. |
https://ClinicalTrials.gov/show/NCT00570492 |
Completed |
GlaxoSmithKline |
2011-03-01 |
| NCT00539006 |
Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS |
https://ClinicalTrials.gov/show/NCT00539006 |
Completed |
GlaxoSmithKline |
2007-11-30 |
| NCT00524836 |
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00524836 |
Completed |
UCB Pharma |
2004-02-29 |
| NCT00521131 |
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites |
https://ClinicalTrials.gov/show/NCT00521131 |
Completed |
UCB Pharma |
2003-05-31 |
| NCT00519636 |
Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS |
https://ClinicalTrials.gov/show/NCT00519636 |
Completed |
GlaxoSmithKline |
2007-11-30 |
| NCT00490204 |
Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00490204 |
Completed |
GlaxoSmithKline |
2007-10-03 |
| NCT00456755 |
Herbal Treatment for Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00456755 |
Completed |
Chinese University of Hong Kong |
2006-04-30 |
| NCT00449072 |
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT00449072 |
Completed |
Sanofi |
2011-10-31 |
| NCT00439712 |
Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00439712 |
Completed |
Institut für Atemwegsforschung GmbH |
2007-05-31 |
| NCT00406783 |
Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) |
https://ClinicalTrials.gov/show/NCT00406783 |
Completed |
Merck Sharp & Dohme Corp. |
2007-11-30 |
| NCT00404586 |
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber |
https://ClinicalTrials.gov/show/NCT00404586 |
Completed |
GlaxoSmithKline |
2007-01-16 |
| NCT00398476 |
Fluticasone Nasal Spray Patient Preference Study |
https://ClinicalTrials.gov/show/NCT00398476 |
Completed |
GlaxoSmithKline |
2006-12-04 |
| NCT00359216 |
The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) |
https://ClinicalTrials.gov/show/NCT00359216 |
Completed |
Merck Sharp & Dohme Corp. |
2008-01-31 |
| NCT00358475 |
Study Of Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00358475 |
Completed |
GlaxoSmithKline |
2005-10-01 |
| NCT00346775 |
Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) |
https://ClinicalTrials.gov/show/NCT00346775 |
Completed |
GlaxoSmithKline |
2006-06-29 |
| NCT00289198 |
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) |
https://ClinicalTrials.gov/show/NCT00289198 |
Completed |
GlaxoSmithKline |
2006-07-01 |
| NCT00261287 |
Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) |
https://ClinicalTrials.gov/show/NCT00261287 |
Completed |
AstraZeneca |
2006-06-30 |
| NCT00257595 |
Perennial Allergic Rhinitis In Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00257595 |
Completed |
GlaxoSmithKline |
NA |
| NCT00253058 |
Study Of Perennial Allergic Rhinitis In Pediatrics |
https://ClinicalTrials.gov/show/NCT00253058 |
Completed |
GlaxoSmithKline |
NA |
| NCT00232518 |
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00232518 |
Completed |
University of Nottingham |
NA |
| NCT00224523 |
Long Term Safety Of GW685698X Via Nasal Biopsy |
https://ClinicalTrials.gov/show/NCT00224523 |
Completed |
GlaxoSmithKline |
2007-02-28 |
| NCT00210015 |
A Study in Subjects With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00210015 |
Completed |
Merck Sharp & Dohme Corp. |
2003-04-30 |
| NCT00163514 |
Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) |
https://ClinicalTrials.gov/show/NCT00163514 |
Completed |
AstraZeneca |
2005-07-31 |
| NCT00163501 |
Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) |
https://ClinicalTrials.gov/show/NCT00163501 |
Completed |
AstraZeneca |
2005-04-30 |
| NCT00163488 |
Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) |
https://ClinicalTrials.gov/show/NCT00163488 |
Completed |
AstraZeneca |
2005-08-31 |
| NCT00160680 |
ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) |
https://ClinicalTrials.gov/show/NCT00160680 |
Completed |
UCB Pharma |
2006-06-01 |
| NCT00160589 |
LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) |
https://ClinicalTrials.gov/show/NCT00160589 |
Completed |
UCB Pharma |
2005-09-30 |
| NCT00159523 |
Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic |
https://ClinicalTrials.gov/show/NCT00159523 |
Completed |
Norwegian University of Science and Technology |
2007-09-30 |
| NCT00132925 |
An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis |
https://ClinicalTrials.gov/show/NCT00132925 |
Completed |
Sanofi |
NA |
| NCT00116883 |
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics |
https://ClinicalTrials.gov/show/NCT00116883 |
Completed |
GlaxoSmithKline |
2005-07-31 |
| NCT00116818 |
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults |
https://ClinicalTrials.gov/show/NCT00116818 |
Completed |
GlaxoSmithKline |
2005-05-31 |
| NCT00109486 |
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray |
https://ClinicalTrials.gov/show/NCT00109486 |
Completed |
GlaxoSmithKline |
2005-11-30 |
| NCT00108914 |
Perennial Allergic Rhinitis Study In Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00108914 |
Completed |
GlaxoSmithKline |
2005-11-30 |
| NCT00107757 |
Seasonal Allergic Rhinitis In Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00107757 |
Completed |
GlaxoSmithKline |
NA |
| NCT00103454 |
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). |
https://ClinicalTrials.gov/show/NCT00103454 |
Completed |
GlaxoSmithKline |
2005-05-31 |
| NCT00092118 |
The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) |
https://ClinicalTrials.gov/show/NCT00092118 |
Completed |
Merck Sharp & Dohme Corp. |
2004-05-31 |
| NCT00092105 |
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) |
https://ClinicalTrials.gov/show/NCT00092105 |
Completed |
Merck Sharp & Dohme Corp. |
2003-01-01 |
| NCT00041821 |
Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity |
https://ClinicalTrials.gov/show/NCT00041821 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
NA |
| NCT00434421 |
Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma |
https://ClinicalTrials.gov/show/NCT00434421 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-08-31 |